BTIG Research Issues Positive Forecast for GE HealthCare Technologies (NASDAQ:GEHC) Stock Price

Key Points

• BTIG Research raised its GE HealthCare price target to $83 from $75 and maintained a “buy” rating, implying 7.92% upside from the prior close. Analysts overall rate the stock “Moderate Buy,” with an average target of $78.70.
• GE HealthCare exceeded quarterly expectations, reporting $1.34 in EPS versus $1.20 expected and revenue of $5.51 billion, up 7.2% year over year. Strong growth and margin expansion supported an increase in fiscal 2026 guidance.
• Shares rose 8.2% to $76.91, while institutional investors continued adding to their positions; hedge funds and other institutions own approximately 82.06% of the stock.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) had its target price increased by equities research analysts at BTIG Research from $75.00 to $83.00 in a report released on Wednesday, Benzinga reports. The brokerage presently has a "buy" rating on the stock. BTIG Research's target price suggests a potential upside of 7.92% from the company's previous close.

A number of other equities research analysts have also commented on the company. Weiss Ratings raised GE HealthCare Technologies from a "hold (c-)" rating to a "hold (c)" rating in a research report on Tuesday, October 6th. Hovde Group assumed coverage on GE HealthCare Technologies in a research note on Friday, July 17th. They issued a "market perform" rating and a $14.00 target price on the stock. Zacks Research upgraded shares of GE HealthCare Technologies from a "strong sell" rating to a "hold" rating in a research note on Tuesday, August 11th. Wells Fargo & Company raised their price target on GE HealthCare Technologies from $75.00 to $85.00 and gave the stock an "overweight" rating in a report on Thursday, July 30th. Finally, Needham & Company LLC reiterated a "buy" rating and set a $93.00 price objective on shares of GE HealthCare Technologies in a research note on Monday, October 5th. One analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating and eleven have assigned a Hold rating to the stock. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $78.70.

GE HealthCare Technologies Stock Up 8.2%

NASDAQ:GEHC traded up $5.80 during trading hours on Wednesday, reaching $76.91. The company had a trading volume of 5,169,222 shares, compared to its average volume of 4,218,494. GE HealthCare Technologies has a twelve month low of $58.75 and a twelve month high of $89.77. The firm has a market cap of $34.74 billion, a price-to-earnings ratio of 17.64, a P/E/G ratio of 1.89 and a beta of 0.73. The business's 50-day simple moving average is $68.30 and its two-hundred day simple moving average is $70.23. The company has a quick ratio of 0.97, a current ratio of 1.26 and a debt-to-equity ratio of 0.92.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last announced its quarterly earnings data on Wednesday, October 28th. The company reported $1.34 EPS for the quarter, beating analysts' consensus estimates of $1.20 by $0.14. GE HealthCare Technologies had a return on equity of 20.12% and a net margin of 9.33%. The firm had revenue of $5.51 billion during the quarter, compared to analysts' expectations of $5.35 billion. During the same quarter last year, the firm posted $1.07 earnings per share. The company's revenue for the quarter was up 7.2% compared to the same quarter last year. On average, equities analysts expect that GE HealthCare Technologies will post 4.93 earnings per share for the current year.

Institutional Inflows and Outflows

Several large investors have recently made changes to their positions in GEHC. Soltis Investment Advisors LLC grew its stake in shares of GE HealthCare Technologies by 10.8% in the third quarter. Soltis Investment Advisors LLC now owns 3,610 shares of the company's stock worth $236,000 after acquiring an additional 353 shares during the last quarter. Choreo LLC increased its holdings in shares of GE HealthCare Technologies by 18.0% during the third quarter. Choreo LLC now owns 32,926 shares of the company's stock valued at $2,152,000 after acquiring an additional 5,013 shares in the last quarter. China Universal Asset Management Co. Ltd. raised its position in shares of GE HealthCare Technologies by 11.1% in the 3rd quarter. China Universal Asset Management Co. Ltd. now owns 15,221 shares of the company's stock worth $1,012,000 after purchasing an additional 1,524 shares during the last quarter. D.A. Davidson & CO. raised its position in shares of GE HealthCare Technologies by 26.0% in the 3rd quarter. D.A. Davidson & CO. now owns 52,980 shares of the company's stock worth $3,463,000 after purchasing an additional 10,944 shares during the last quarter. Finally, North Dakota State Investment Board boosted its stake in GE HealthCare Technologies by 2.2% in the 3rd quarter. North Dakota State Investment Board now owns 13,911 shares of the company's stock worth $909,000 after purchasing an additional 301 shares in the last quarter. 82.06% of the stock is owned by hedge funds and other institutional investors.

More GE HealthCare Technologies News

Here are the key news stories impacting GE HealthCare Technologies this week:

• Positive Sentiment: GE HealthCare reported third-quarter adjusted earnings of $1.34 per share, above the $1.20-$1.21 analyst consensus and up from $1.07 a year earlier. Revenue rose 7.2% year over year to $5.51 billion, exceeding estimates of roughly $5.35 billion. GE HealthCare Technologies Q3 Earnings and Revenues Beat Estimates
• Positive Sentiment: Management cited strong top-line growth, margin expansion across all segments, disciplined operations and continued customer adoption of new products. Higher earnings and improved operating performance supported the increase in the company’s fiscal 2026 guidance. GE HealthCare Reports Third Quarter 2026 Financial Results
• Positive Sentiment: Analysts highlighted broad segment growth and higher margins as the main drivers of the earnings beat, suggesting that strong imaging demand and GE HealthCare’s backlog are translating into improved profitability. GEHC Q3 Earnings Beat Estimates on Strong Growth, 2026 View Raised
• Neutral Sentiment: Jeannette Bankes, president and CEO of Patient Care Solutions, will leave GE HealthCare for a CEO position at another company. The leadership change could create a near-term transition issue, although no operational impact was announced. GE HealthCare Shares Rise on Higher Q3 Results and FY26 Outlook Upgrade
• Negative Sentiment: Before the results, investors were watching for inflation, supply-chain constraints and potential weakness in Patient Care Solutions to pressure margins. The quarter’s margin expansion and guidance increase appear to have reduced those concerns, but they remain risks to monitor. GEHC Ahead of Q3 Earnings

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc is a global medical technology company that develops and provides products, services and digital solutions for healthcare providers. Its offerings are designed to support the diagnosis, treatment and monitoring of patients across hospitals, outpatient facilities, imaging centers and other care settings.

The company's portfolio includes medical imaging systems such as computed tomography, magnetic resonance imaging, molecular imaging, surgical imaging and X-ray equipment.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.